Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Robust myelin quantitative imaging from multi-echo T2 MRI using edge preserving spatial priors.
Human Herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via TLR9.
Regulation of Experimental Autoimmune Encephalomyelitis by TPL-2 Kinase.
Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-γ and alpha B-crystallin.
Recognising and diagnosing inflammatory brain disease.
Epileptic seizures in multiple sclerosis: a population-based survey in Iran.
C16 peptide shown to prevent leukocyte infiltration and alleviate detrimental inflammation in acute allergic encephalomyelitis model.
Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks.
Nexium | Where To Buy Next
Using EAE to better understand principles of immune function and autoimmune pathology.
Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
Isolated bilateral horizontal gaze palsy as first manifestation of multiple sclerosis.
Use of Accelerometers to Measure Real-Life Physical Activity in Ambulatory Individuals with Multiple Sclerosis: A Pilot Study.
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications.
Facial hypersensitivity and trigeminal pathology in mice with experimental autoimmune encephalomyelitis (EAE).
Safety and efficacy of reduced fingolimod dosage treatment.
The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response.
Causes of upregulation of glycolysis in lymphocytes upon stimulation. A comparison with other cell types.
Sequencing the immunopathologic heterogeneity in multiple sclerosis.
The role of MRI in the evaluation of secondary progressive multiple sclerosis.
Increased S-nitrosothiols are associated with spinal cord injury in multiple sclerosis.
Regulatory T-Cells in Chronic Lymphocytic Leukemia and Autoimmune Diseases.
Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies?
High-affinity sigma-1 protein agonist reduces clinical and pathological signs of experimental auto-immune encephalomyelitis.
Pages
« first
‹ previous
…
444
445
446
447
448
449
450
451
452
…
next ›
last »